Heterogeneity of outcomes of endometrial cancer patients included in prospective clinical trials.

MLA

Boone, Ryan M., et al. “Heterogeneity of Outcomes of Endometrial Cancer Patients Included in Prospective Clinical Trials.” Gynecologic Oncology, vol. 169, Feb. 2023, pp. 70–77. EBSCOhost, https://doi.org/10.1016/j.ygyno.2022.11.022.

APA

Boone, R. M., Praiss, A. M., Huang, Y., Melamed, A., Khoury-Collado, F., Hou, J. Y., Gockley, A., St Clair, C. M., Hershman, D. L., & Wright, J. D. (2023). Heterogeneity of outcomes of endometrial cancer patients included in prospective clinical trials. Gynecologic Oncology, 169, 70–77. https://doi.org/10.1016/j.ygyno.2022.11.022

Chicago

Boone, Ryan M, Aaron M Praiss, Yongmei Huang, Alexander Melamed, Fady Khoury-Collado, June Y Hou, Allison Gockley, Caryn M St Clair, Dawn L Hershman, and Jason D Wright. 2023. “Heterogeneity of Outcomes of Endometrial Cancer Patients Included in Prospective Clinical Trials.” Gynecologic Oncology 169 (February): 70–77. doi:10.1016/j.ygyno.2022.11.022.